UBS Group AG - ALLARITY THERAPEUTICS INC ownership

ALLARITY THERAPEUTICS INC's ticker is and the CUSIP is 016744104. A total of 11 filers reported holding ALLARITY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ALLARITY THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$11
-99.9%
39
-99.7%
0.00%
Q3 2022$15,000
+400.0%
13,946
+582.0%
0.00%
Q2 2022$3,000
-66.7%
2,045
-54.3%
0.00%
Q1 2022$9,000
+800.0%
4,479
+4009.2%
0.00%
Q4 2021$1,0001090.00%
Other shareholders
ALLARITY THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 20,000$26,0000.00%
LMR Partners LLP 46,033$61,0000.00%
UBS Group AG 2,045$3,0000.00%
BANK OF AMERICA CORP /DE/ 1,306$2,0000.00%
WELLS FARGO & COMPANY/MN 51$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 29,433$38,0000.00%
STATE STREET CORP 12,974$17,0000.00%
MORGAN STANLEY 148$00.00%
CITIGROUP INC 32,559$43,0000.00%
View complete list of ALLARITY THERAPEUTICS INC shareholders